Literature DB >> 3267021

Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat.

S L Lightman1, W S Young.   

Abstract

1. Rats underwent either: (1) acute or chronic morphine or naloxone administration; (2) simple morphine withdrawal or naloxone-precipitated withdrawal in morphine-dependent animals; or (3) stress from I.P. administration of hypertonic saline. 2. Quantitative in situ hybridization histochemistry was performed using synthetic oligonucleotide probes for corticotrophin-releasing factor (CRF), vasopressin, pro-opiomelanocortin (POMC), dynorphin, enkephalin and oxytocin mRNAs. The paraventricular and supraoptic nuclei were examined in all studies and the arcuate nucleus and pituitary gland in the acute withdrawal study. 3. Neither acute nor chronic morphine administration altered either (a) hypothalamic parvocellular or magnocellular CRF mRNA, or (b) anterior pituitary or pars intermedia POMC mRNA. 4. Naloxone-precipitated morphine withdrawal resulted in a marked increase in parvocellular (but not magnocellular) CRF mRNA within 4 h and levels remained elevated through 24 h. There was no change in arcuate nucleus or pars intermedia POMC mRNA, but in the anterior pituitary there was a delayed increase, significant at 24 h. 5. Simple morphine withdrawal without the use of naloxone did not result in any change in CRF mRNA but there were increases in magnocellular vasopressin and dynorphin mRNA, presumably related to decreased water intake. 6. Intraperitoneal hypertonic saline stress also resulted in a marked accumulation of both parvocellular CRF and vasopressin mRNA without any concomitant change in magnocellular vasopressin mRNA. Increased translation of CRF mRNA was also evidenced by increased immunoreactive CRF detected by immunocytochemistry.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3267021      PMCID: PMC1190725          DOI: 10.1113/jphysiol.1988.sp017261

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  35 in total

1.  Oral ingestion of narcotic analgesics by rats.

Authors:  D E McMillan; J D Leander; T W Wilson; S C Wallace; T Fix; S Redding; R T Turk
Journal:  J Pharmacol Exp Ther       Date:  1976-02       Impact factor: 4.030

2.  Potentiation by vasopressin of corticotropin release induced by corticotropin-releasing factor.

Authors:  F E Yates; S M Russell; M F Dallman; G A Hodge; S M McCann; A P Dhariwal
Journal:  Endocrinology       Date:  1971-01       Impact factor: 4.736

3.  Corticotropin-releasing factor. Proceedings of a conference, February 20-24, 1984 sponsored by the Kroc Foundation.

Authors: 
Journal:  Fed Proc       Date:  1985-01

4.  Immunoreactive vasopressin and oxytocin in hypothalamo-hypophysial portal blood of the Brattleboro and Long-Evans rat: effect of adrenalectomy and dexamethasone.

Authors:  D J Eckland; K Todd; S L Lightman
Journal:  J Endocrinol       Date:  1988-04       Impact factor: 4.286

5.  Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia.

Authors:  P M Plotsky; T O Bruhn; W Vale
Journal:  Endocrinology       Date:  1985-07       Impact factor: 4.736

6.  Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.

Authors:  J C Buckingham; T A Cooper
Journal:  Neuroendocrinology       Date:  1984-05       Impact factor: 4.914

7.  Co-localization of corticotropin-releasing factor and vasopressin in median eminence neurosecretory vesicles.

Authors:  M H Whitnall; E Mezey; H Gainer
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

8.  Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat.

Authors:  P E Sawchenko; L W Swanson; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

9.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.

Authors:  L W Swanson; P E Sawchenko; J Rivier; W W Vale
Journal:  Neuroendocrinology       Date:  1983       Impact factor: 4.914

10.  Hemorrhage-induced secretion of corticotropin-releasing factor-like immunoreactivity into the rat hypophysial portal circulation and its inhibition by glucocorticoids.

Authors:  P M Plotsky; W Vale
Journal:  Endocrinology       Date:  1984-01       Impact factor: 4.736

View more
  30 in total

1.  Nramp1 is expressed in neurons and is associated with behavioural and immune responses to stress.

Authors:  C A Evans; M S Harbuz; T Ostenfeld; A Norrish; J M Blackwell
Journal:  Neurogenetics       Date:  2001-03       Impact factor: 2.660

Review 2.  The molecular biology of addictive drugs.

Authors:  S A Mackler; J H Eberwine
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

Review 3.  60 YEARS OF NEUROENDOCRINOLOGY: The structure of the neuroendocrine hypothalamus: the neuroanatomical legacy of Geoffrey Harris.

Authors:  Alan G Watts
Journal:  J Endocrinol       Date:  2015-05-20       Impact factor: 4.286

4.  Influence of steroids on the hypothalamic corticotropin-releasing factor and preproenkephalin mRNA responses to stress.

Authors:  S L Lightman; W S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats.

Authors:  E M Sternberg; W S Young; R Bernardini; A E Calogero; G P Chrousos; P W Gold; R L Wilder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoids in rats.

Authors:  T Imaki; W Xiao-Quan; T Shibasaki; K Yamada; S Harada; N Chikada; M Naruse; H Demura
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Changes in vasoactive intestinal peptide and arginine vasopressin expression in the suprachiasmatic nucleus of the rat brain following footshock stress.

Authors:  Robert J Handa; R Thomas Zoeller; Robert F McGivern
Journal:  Neurosci Lett       Date:  2007-08-25       Impact factor: 3.046

8.  The arginine vasopressin and corticotrophin-releasing hormone gene transcription responses to varied frequencies of repeated stress in rats.

Authors:  X M Ma; S L Lightman
Journal:  J Physiol       Date:  1998-07-15       Impact factor: 5.182

Review 9.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

10.  Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.

Authors:  J A Russell; J E Coombes; G Leng; R J Bicknell
Journal:  J Physiol       Date:  1993-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.